ArticlePublic health reports (Washington, D.C. : 1974)
Roles for Pharmacists in the "Ending the HIV Epidemic: A Plan for America" Initiative.
Article in Public health reports (Washington, D.C. : 1974). The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06487351 (The Impact of an Intervention to Reduce Pharmacists' Racial Bias Towards People of Color at Risk of HIV), which is not on this map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Impact of an Intervention to Reduce Pharmacists' Racial Bias Towards People of Color at Risk of HIV
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The role of pharmacists and pharmacy team members in the prevention, preparedness, response and recovery of outbreaks - a global rapid systematic review.BMC public health · 2026Pooled it
- Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People with HIV in Project CoRECT: A Mixed Methods Study.AIDS and behavior · 2025Trial
- The PrEP Pharmacy Reach Study: Protocol for the Creation of Maps to Visualize the Impact of Expanding Access to HIV Prevention Services Through Pharmacies.JMIR public health and surveillance · 2025Article
- Identifying Health Care Services Offered in the HIV Care Continuum via a Machine Learning-Based Topic Modeling Approach: Exploratory Literature Review.JMIR public health and surveillance · 2025Review
- Preparing for pharmacy-based delivery of long-acting injectable antiretrovirals: a pre-implementation study.BMC health services research · 2025Observational
- Innovation in Providing Equitable Pre-exposure Prophylaxis Services in the United States: Expanding Access in Nontraditional Settings.Journal of acquired immune deficiency syndromes (1999) · 2025Article
- Using the andersen healthcare utilization model to assess willingness to screen for prep in pharmacy-based settings among cisgender sexually minoritized men: results from the 2020 american men's internet survey.BMC public health · 2024Article
- Implementation strategies and outcomes in the delivery of HIV test services (HTS) in community pharmacies in Nigeria.BMC primary care · 2024Article
- Needs-Assessment for an Artificial Intelligence-Based Chatbot for Pharmacists in HIV Care: Results from a Knowledge-Attitudes-Practices Survey.Healthcare (Basel, Switzerland) · 2024Article
- Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States.Current HIV/AIDS reports · 2024Review
- HIV pre-exposure prophylaxis champion preceptorship training for pharmacists and nurses in the United States.Journal of the American College of Clinical Pharmacy : JACCP · 2024Article
- Exploring the intersectionality of racism and sexual/gender minority health: A call to action for health-system pharmacists.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2024Article
- 2023 Update to the American College of Clinical Pharmacy Pharmacotherapy Didactic Curriculum Toolkit.Journal of the American College of Clinical Pharmacy : JACCP · 2024Article
- Facilitators and barriers to community pharmacy PrEP delivery: a scoping review.Journal of the International AIDS Society · 2024Article
- Availability and accessibility of HIV self-tests and self-sample kits at community pharmacies in the Netherlands.AIDS research and therapy · 2023Article
- A qualitative inquiry into the patient-related barriers to linkage and retention in HIV care within the community setting.Exploratory research in clinical and social pharmacy · 2023Article
- Potential roles of pharmacists in HIV/AIDS care delivery in Nepal: A qualitative study.PloS one · 2023Article
- Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review.AIDS and behavior · 2022Article
- Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake.Exploratory research in clinical and social pharmacy · 2021Article
- Patients, Social Workers, and Pharmacists' Perceptions of Barriers to Providing HIV Care in Community Pharmacies in the United States.Pharmacy (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2019, President Trump announced a new initiative, Ending the HIV Epidemic: A Plan for America (EHE). EHE will use 3 key strategies-diagnose, treat, and prevent-to reduce new HIV infections at least 90% by 2030, as well as new laboratory methods and epidemiological techniques to respond quickly to potential outbreaks. Partnerships are an important component in the initiative's success. Pharmacists and pharmacies can play important roles in EHE, including dispensing antiretroviral therapy and providing HIV screening, adherence counseling, medication therapy management, preexposure prophylaxis, and nonprescription syringe sales. The objective of this report is to discuss potential roles that pharmacists and pharmacies can play under the key strategies of EHE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.